|
1
|
WHO: Global tuberculosis report. World
Health Organization; France: pp. 1–89. 2012
|
|
2
|
Cooper AM: Cell-mediated immune responses
in tuberculosis. Annu Rev Immunol. 27:393–422. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Natarajan K, Kundu M, Sharma P and Basu J:
Innate immune responses to M. tuberculosis infection. Tuberculosis
(Edinb). 91:427–431. 2011. View Article : Google Scholar
|
|
4
|
Smith I: Mycobacterium tuberculosis
pathogenesis and molecular determinants of virulence. Clin
Microbiol Rev. 16:463–496. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Russell DG, Barry CE III and Flynn JL:
Tuberculosis: What we don't know can and does, hurt us. Science.
328:852–856. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Riendeau CJ and Kornfeld H: THP-1 cell
apoptosis in response to Mycobacterial infection. Infect Immun.
71:254–259. 2003. View Article : Google Scholar :
|
|
7
|
Khalilullah SA, Harapan H, Hasan N,
Winardi W, Ichsan I and Mulyadi M: Host genome polymorphisms and
tuberculosis infection: What we have to say? Egyptian Journal of
Chest Diseases and Tuberculosis. 63:173–85. 2014. View Article : Google Scholar
|
|
8
|
Akita T, Takuno S and Innan H: Modeling
evolutionary growth of a microRNA-mediated regulation system. J
Theor Biol. 311:54–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kanwar JR, Mahidhara G and Kanwar RK:
MicroRNA in human cancer and chronic inflammatory diseases. Front
Biosci (Schol Ed). 2:1113–1126. 2010.
|
|
10
|
Chen XM: MicroRNA signatures in liver
diseases. World J Gastroenterol. 15:1665–1672. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Christensen M and Schratt GM: MicroRNA
involvement in developmental and functional aspects of the nervous
system and in neurological diseases. Neurosci Lett. 466:55–62.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pauley KM, Cha S and Chan EK: MicroRNA in
autoimmunity and autoimmune diseases. J Autoimmun. 32:189–194.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodriguez A, Vigorito E, Clare S, Warren
MV, Couttet P, Soond DR, van Dongen S, Grocock RJ, Das PP, Miska
EA, et al: Requirement of bic/microRNA-155 for normal immune
function. Science. 316:608–611. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Curtale G, Citarella F, Carissimi C,
Goldoni M, Carucci N, Fulci V, Franceschini D, Meloni F, Barnaba V
and Macino G: An emerging player in the adaptive immune response:
MicroRNA-146a is a modulator of IL-2 expression and
activation-induced cell death in T lymphocytes. Blood. 115:265–273.
2010. View Article : Google Scholar
|
|
15
|
Liu Y, Wang X, Jiang J, Cao Z, Yang B and
Cheng X: Modulation of T cell cytokine production by miR-144* with
elevated expression in patients with pulmonary tuberculosis. Mol
Immunol. 48:1084–1090. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marín ND, París SC, Rojas M and García LF:
Reduced frequency of memory T cells and increased Th17 responses in
patients with active tuberculosis. Clin Vaccine Immunol.
19:1667–1676. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsitsiou E and Lindsay MA: MicroRNAs and
the immune response. Curr Opin Pharmacol. 9:514–520. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu R, Kagele DA, Huffaker TB, Runtsch MC,
Alexander M, Liu J, Bake E, Su W, Williams MA, Rao DS, et al:
miR-155 promotes T follicular helper cell accumulation during
chronic, low-grade inflammation. Immunity. 41:605–619. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rajaram MV, Ni B, Morris JD, Brooks MN,
Carlson TK, Bakthavachalu B, Schoenberg DR, Torrelles JB and
Schlesinger LS: Mycobacterium tuberculosis lipomannan blocks TNF
biosynthesis by regulating macrophage MAPK-activated protein kinase
2 (MK2) and microRNA miR-125b. Proc Natl Acad Sci USA.
108:17408–17413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bala S, Marcos M, Kodys K, Csak T,
Catalano D, Mandrekar P and Szabo G: Up-regulation of microRNA-155
in macrophages contributes to increased tumor necrosis factor
{alpha} (TNF{alpha}) production via increased mRNA half-life in
alcoholic liver disease. J Biol Chem. 286:1436–1444. 2011.
View Article : Google Scholar :
|
|
21
|
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo
P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arden KC: FOXO animal models reveal a
variety of diverse roles for FOXO transcription factors. Oncogene.
27:2345–2350. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peng SL: Foxo in the immune system.
Oncogene. 27:2337–2344. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ticchioni M, Essafi M, Jeandel PY, Davi F,
Cassuto JP, Deckert M and Bernard A: Homeostatic chemokines
increase survival of B-chronic lymphocytic leukemia cells through
inactivation of transcription factor FOXO3a. Oncogene.
26:7081–7091. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Haoues M, Refai A, Mallavialle A,
Barbouche MR, Laabidi N, Deckert M and Essafi M: Forkhead box O3
(FOXO3) transcription factor mediates apoptosis in BCG-infected
macrophages. Cell Microbiol. 16:1378–1390. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harada Y, Harada Y, Elly C, Ying G, Paik
JH, DePinho RA and Liu YC: Transcription factors Foxo3a and Foxo1
couple the E3 ligase Cbl-b to the induction of Foxp3 expression in
induced regulatory T cells. J Exp Med. 207:1381–1391. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ling N, Gu J, Lei Z, Li M, Zhao J, Zhang
HT and Li X: MicroRNA-155 regulates cell proliferation and invasion
by targeting FOXO3a in glioma. Oncol Rep. 30:2111–2118.
2013.PubMed/NCBI
|
|
28
|
Zhang L, Liu S, Zhang L, You H, Huang R,
Sun L, He P, Chen S, Zhang H and Xie P: Real-time qPCR identifies
suitable reference genes for Borna disease virus-infected rat
cortical neurons. Int J Mol Sci. 15:21825–21839. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu Y, Jiang J, Wang X, Zhai F and Cheng
X: MiR-582-5p is upregulated in patients with active tuberculosis
and inhibits apoptosis of monocytes by targeting FOXO1. PloS One.
8:e783812013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu J, Lu C, Diao N, et al: Analysis of
microRNA expression profiling identifies miR-155 and miR-155* as
potential diagnostic markers for active tuberculosis: A preliminary
study. Hum Immunol. 73:31–37. 2012. View Article : Google Scholar
|
